A prognostic analysis of male breast cancer (MBC)comparing with post-menopausal female breast cancer

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：aptxkid2009

【摘要】

：

Objective: It is a widely known fact that male breast cancer(MBC) is a rare disease compared with female breast cancer (FBC) and account for only 1% of all breast cancers.

【作者】

：

Xing-fei Yu Yang Hong-jian Miao Lu-lu

【机构】

：

Breast Tumor Surgery, Zhejiang Cancer Hospital De

【出处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年4期

【关键词】

：

male breast cancer female breast cancer post-menopausal

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective: It is a widely known fact that male breast cancer(MBC) is a rare disease compared with female breast cancer (FBC) and account for only 1% of all breast cancers.

其他文献

Down-regulation of c-Met and Bcl2 by MicroRNA-206,Activates Apoptosis, and Inhibits Tumor Cell Proli

Objective: Hsa-miRNA-206 (miR-206), highly expressed inskeletal muscle, has recently been discovered to have anticancer properties indifferent tissues.However, the role of miR-206 on lung cancer is st

会议

hsa-miRNA-206c-MetBcl2

30例颅内室管膜瘤术后放射治疗的临床分析

目的：讨论颅内室管膜瘤的临床特点和治疗转归。方法：回顾性分析2009年1月～2012年6月收治的经病理证实的30例颅内室管膜瘤术后放射治疗患者的临床资料，观察疗效并结合文献进行分析。

会议

室管膜瘤手术放射治疗

MiR-326 regulates cell proliferation and migration in lung cancer by targeting Phox2a and is regulat

Objective: MicroRNA plays a crucial role in development and progression of multiple malignancies.However, the mechanisms of microRNA in cancer are not totally clear.

会议

miR-326lung cancercell proliferation and migrate

Combination of Angiogenesis Inhibitor (Endostar) and EGFR-TKIs in Patients with Advanced Non-small c

Objective: To evaluate the clinical activity of angiogenesis inhibitor Endostar (rh-endostatin) in combination with continued EGFR-TKIs (including erlotinib, gefitinib and IcotinibO) for advanced NSCL

会议

EndostarEGFR-TKIsNon-small cell lung cancer

The treatment with dose-escalated icotinib after resistance to routine dose of icotinib for the pati

Objective: To evaluate the efficacy of treatment with dose-escalated icotinib after resistance to routine dose of icotinib for the patients of the advanced non-smoll cell lung cancer.

会议

non-smoll cell lung cancericotinibdose-escalated

再次肿瘤组织活检对复发性肺癌精准治疗的重要意义探索性研究

目的：近年来针对肿瘤内部异质性的探索成为了新的研究热点。大多数肺癌在最初阶段对治疗一定程度的有效反应。经过一段时期后，残留的癌细胞亚群可致肿瘤复发或者转移。复发瘤的癌细胞遗传不稳定性增强，给临床治疗带来不小的障碍。

会议

肺癌肿瘤异质性再次肿瘤组织活检

埃克替尼靶向治疗期间手术干预的非小细胞肺癌10例临床分析

目的：探讨埃克替尼靶向治疗期间适时手术干预治疗非小细胞肺癌的可行性。方法：对我科经埃克替尼靶向治疗后在不同时机采取手术干预的10例患者进行回顾性分析。结果：10例患者经埃克替尼靶向治疗后均施行手术干预治疗，其中行左全肺切除1例，肺叶切除6例，局部切除3例。

会议

埃克替尼手术干预非小细胞肺癌

剂量-体积直方图参数预测肺癌患者术后放疗发生急性严重放射性肺炎的回顾性分析

目的：在既往报道中，典型的剂量-体积直方图(DVH)参数是肺癌患者放射治疗后发生放射性肺炎(RP)的预测因素。然而，上述剂量学因素和RP这二者相关的讨论仅在局限的治疗环境中。因此，在本文中我们回顾性评估了DVH对术后放射治疗(PORT)后的肺癌患者发生急性重度放射性肺炎(ASRP)可能存在的预测作用。

会议

放射性肺炎术后放射治疗剂量-体积直方图

High expression of PKM2 is associated with good sensitivity to epirubicin and 5-fluorouracil in brea

Objective: Pyruvatekinase M2 (PKM2) is the key enzyme in Warburg effect and was reported to be involved in metabolic pathways of tumor cells response to chemotherapeutic drugs recently.

会议

breast cancerchemosensitivityPKM2

PEGylated Gold Nanoprisms for Photothermal Therapy at Low Laser Power Density

Objective: Photothermal therapy (PTT) has emerge as a promising way to treat cancer with minimal invasion and high selectivity.The purpose of this study was to synthesis gold nanoprisms (GNPs) as a ne

会议

photothermal therapygold nanoparticlesbreast cancer

A prognostic analysis of male breast cancer (MBC)comparing with post-menopausal female breast cancer

其他学术论文